Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Yeast GTP-binding protein (
YPT1
protein) has been reported to function in the early stages of the secretory pathway. Particularly,
YPT1
protein is observed to regulate both the endoplasmic reticulum-to-Golgi transport and the autophagy. Therefore, the
YPT1
protein overexpressed in yeast vacuoles is expected to enhance antimicrobial and anticancer activity. The enhancement of yeast vacuolar activity under the overexpression of
YPT1
was evaluated by the analysis of
lysozyme
activity, antimicrobial activity against Escherichia coli and Staphylococcus aureus, and MTT assay against HeLa cell lines. Additionally, the rise in concentration of some important proteinases inside the vacuole, such as proteinase A, proteinase B, and vacuolar carboxypeptidase Y (CPY) were also recorded using a 2DE technique. All results imply
YPT1
involvement in the recruitment of some specific proteinases into vacuoles, which leads to the enhancement of vacuolar activity. Since these there proteinases belong to the CPY pathway,
YPT1
is even believed to up-regulate this trafficking pathway in yeast cells. Future studies, however, should be carried out to discover the mechanisms that allow
YPT1
to recruit these proteins into yeast vacuoles.
...
PMID:Effect of GTP-binding protein (YPT1 protein) on the enhanced yeast vacuolar activity. 2689 20